Detalhe da pesquisa
1.
Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.
Jpn J Clin Oncol
; 53(3): 221-229, 2023 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533429
2.
The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434).
Invest New Drugs
; 39(1): 152-162, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32564277
3.
First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.
Cancer Sci
; 111(12): 4480-4489, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32926507
4.
KEYNOTE-025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1-positive advanced non-small-cell lung cancer.
Cancer Sci
; 110(3): 1012-1020, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30618179
5.
Effectiveness on high-grade cervical abnormalities and long-term safety of the quadrivalent human papillomavirus vaccine in Japanese women.
J Infect Chemother
; 25(7): 520-525, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30879979
6.
Efficacy, safety, and immunogenicity of a quadrivalent HPV vaccine in Japanese men: A randomized, Phase 3, placebo-controlled study.
Vaccine
; 37(12): 1651-1658, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30797638
7.
Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1-positive advanced non-small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies.
Lung Cancer
; 135: 188-195, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31446994